The protective role of maternally derived antibodies against bordetella pertussis in young infants

Pediatric Infectious Disease Journal

Volumn 32, Issue 6, 2013, Pages 695-698

  Heininger, Ulrich ^a   Riffelmann, Marion ^b   Bär, Gurli ^a   Rudin, Christoph ^a   Von König, Carl Heinz Wirsing ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Labor: Medizin Krefeld MVZ   (Germany)

Author keywords

Bordetella pertussis; Enzyme linked immunosorbent assay; Immunity; Maternally acquired; Pertussis

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; PERTUSSIS TOXIN;

ARTICLE; BORDETELLA PERTUSSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; IMMUNIZATION; INFANT; PERTUSSIS; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ANTIBODIES, BACTERIAL; ANTITOXINS; BORDETELLA PERTUSSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; WHOOPING COUGH;

EID: 84879201313     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318288b610     Document Type: Article

References (16)

1. Heininger U, Stehr K, Cherry JD. Serious pertussis overlooked in infants. Eur J Pediatr. 1992;151:342-343.
2. Kowalzik F, Barbosa A P, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J. 2007;26:238-242.
3. Juretzko P, von Kries R, Hermann M, et al. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis. 2002;35:162-167.
4. Heininger U. Update on pertussis in children. Expert Rev Anti Infect Ther. 2010;8:163-173.
5. Klein N P, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367:1012-1019.
6. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54:1730-1735.
7. Heininger U, Riffelmann M, Leineweber B, et al. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns. Pediatr Infect Dis J. 2009;28:443-445.
8. Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J. 2005;24(suppl 5):S62-S65.
9. Wirsing von König CH, Gounis D, Laukamp S, et al. Evaluation of a singlesample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis. 1999;18:341-345.
10. Xing D, Wirsing von König CH, Newland P, et al. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol. 2009;16:303-311.
11. Higgs R, Higgins SC, Ross PJ, et al. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 2012;5:485-500.
12. Vermeulen F, Verscheure V, Damis E, et al. Cellular immune responses in preterm infants after vaccination with whole-cell or acellular pertussis vaccines. Clin Vaccine Immunol. 2010;17:258-262.
13. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055-1065.
14. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152:655-660.
15. Knuf M, Schmitt HJ, Jacquet JM, et al. Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr. 2010;156: 675-678.
16. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1424-1426.